Edition:
India

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

3.48USD
16 Nov 2018
Change (% chg)

$0.10 (+2.96%)
Prev Close
$3.38
Open
$3.34
Day's High
$3.50
Day's Low
$3.26
Volume
190,351
Avg. Vol
106,913
52-wk High
$9.69
52-wk Low
$3.05

Chart for

About

Pieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Its Anticalins proteins are a class of low... (more)

Overall

Beta: --
Market Cap(Mil.): $276.04
Shares Outstanding(Mil.): 44.31
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates